American Herbal Products Association (AHPA) > News > Latest News

AHPA NDI Database shows 15 of 59 most recent NDI notifications acknowledged by FDA without objection

18 NDI notifications were considered incomplete

Fifteen (or roughly 25 percent) of the 59 New Dietary Ingredient (NDI) notifications submitted to the Food and Drug Administration (FDA) between November 2015 and October 2016 were acknowledged without objection, according to the latest data uploaded to AHPA's NDI Database.
Meet the 2017-18 AHPA Board of Trustees

Meet the 2017-18 AHPA Board of Trustees

11 members elected to serve three-year terms

The American Herbal Products Association (AHPA) congratulates the 11 members who were elected to serve three-year terms on the board of trustees during the association's annual member meeting on March 9 in Anaheim, Calif.

AHPA adopts labeling guidance for fungi products

Guidance becomes effective March 9, 2019

The Board of Trustees of the American Herbal Products Association (AHPA) at its March 9, 2017 meeting authorized issuance of guidance for labeling products that contain fungi ingredients.
AHPA awards Elwood Richard, Scott Bass, Loren Israelsen, Suzanne Shelton and BI Nutraceuticals

AHPA awards Elwood Richard, Scott Bass, Loren Israelsen, Suzanne Shelton and BI Nutraceuticals

AHPA and the entire herbal products industry have greatly benefited from their years of dedication and hard work

The American Herbal Products Association (AHPA) presented its 2017 awards to Elwood Richard, Scott Bass, Loren Israelsen, Suzanne Shelton and BI Nutraceuticals for substantive and positive contributions to the herbal products industry

CRN/ACI Annual Legal, Regulatory and Compliance Forum on Dietary Supplements

In-depth discussions on the myriad legal, regulatory, and compliance obligations that impact business decisions

Jun 26-28, 2017 -- New York City

Trump administration regulatory stop and review in the February 2017 AHPA Report!

February 2017 AHPA Report

AHPA expresses support for synthetic cannabinoids being placed into schedule I

AHPA submits comments to DEA

The American Herbal Products Association (AHPA) expressed strong support for the Drug Enforcement Agency (DEA) using its temporary scheduling authority to place synthetic cannabinoids into schedule I in comments submitted to the agency.

AHPA responds to inaccurate media coverage of curcumin mini-perspective

Mini-perspective has been misinterpreted to create inaccurate headlines and articles that misinform the public about turmeric

AHPA Chief Science Officer Maged Sharaf, Ph.D., responded to inaccurate media coverage of a mini-perspecive, "The Essential Medicinal Chemistry of Curcumin,"

Sharaf to discuss AHPA initiatives at 17th annual ICBS in Mississippi

Takeaways from FDA inspections webinar and DEA regulations regarding tableting, encapsulating equipment in the January 2017 AHPA Report!

January 2017 AHPA Report

RSS
12345678910 Last

2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.